Clinical and genetic features of a cohort of patients with myoadenilate deaminase deficiency: a new mutation
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingNeurofilament light chain as clinical plasma biomarker of Charcot-Marie-Tooth disease
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSteroid-sparing effect of Eculizumab therapy in patients with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSMN circ4-2b-3 is expressed in nusinersen treated SMA I children and correlates with motor outcomes
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingCardiac risk and myocardial fibrosis assessment with Cardiac Magnetic Resonance in patients with Myotonic Dystrophy
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingEfgartigimod in non-AChR generalized myasthenia gravis
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSwitching treatment to cipaglucosidase alfa plus miglustat positively affects motor function and quality of life in patients with late-onset Pompe disease
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingEarly neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingExtensive next-generation sequencing approaches for the identification of rare genomic structural variants involving the DMD gene
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences